S&P 500

5.431,60

-0,04%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
PMV Pharmaceuticals Inc (PMVP)
PMV Pharmaceuticals Inc (PMVP) Notícias

PMVP

PMV Pharmaceuticals (PMVP)

PMV Pharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PMVP

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
10/06/2024	17:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PMVP	PMV Pharmaceuticals Inc
07/06/2024	09:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PMVP	PMV Pharmaceuticals Inc
30/05/2024	08:00	GlobeNewswire Inc.	PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June	NASDAQ:PMVP	PMV Pharmaceuticals Inc
29/05/2024	08:00	Business Wire	Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator	NASDAQ:PMVP	PMV Pharmaceuticals Inc
09/05/2024	09:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PMVP	PMV Pharmaceuticals Inc
09/05/2024	09:00	GlobeNewswire Inc.	PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc
27/03/2024	09:00	GlobeNewswire Inc.	PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors	NASDAQ:PMVP	PMV Pharmaceuticals Inc
18/03/2024	17:01	GlobeNewswire Inc.	PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer	NASDAQ:PMVP	PMV Pharmaceuticals Inc
29/02/2024	18:01	GlobeNewswire Inc.	PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc
26/02/2024	10:00	GlobeNewswire Inc.	PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:PMVP	PMV Pharmaceuticals Inc
24/01/2024	11:01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PMVP	PMV Pharmaceuticals Inc
18/01/2024	18:01	GlobeNewswire Inc.	PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway	NASDAQ:PMVP	PMV Pharmaceuticals Inc
11/01/2024	18:18	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PMVP	PMV Pharmaceuticals Inc
05/01/2024	18:01	GlobeNewswire Inc.	PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development	NASDAQ:PMVP	PMV Pharmaceuticals Inc
09/11/2023	10:00	GlobeNewswire Inc.	PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc
12/10/2023	13:30	GlobeNewswire Inc.	PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation	NASDAQ:PMVP	PMV Pharmaceuticals Inc
11/10/2023	13:00	GlobeNewswire Inc.	PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar	NASDAQ:PMVP	PMV Pharmaceuticals Inc
20/09/2023	17:05	GlobeNewswire Inc.	PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	NASDAQ:PMVP	PMV Pharmaceuticals Inc
09/08/2023	09:00	GlobeNewswire Inc.	PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc
12/06/2023	18:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
09/06/2023	09:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
06/06/2023	17:01	GlobeNewswire Inc.	PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference	NASDAQ:PMVP	PMV Pharmaceuticals Inc
10/05/2023	09:00	GlobeNewswire Inc.	PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc
01/05/2023	07:20	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
28/04/2023	09:05	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
28/04/2023	09:03	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
28/04/2023	09:02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
01/03/2023	10:06	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PMVP	PMV Pharmaceuticals Inc
01/03/2023	10:00	GlobeNewswire Inc.	PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights	NASDAQ:PMVP	PMV Pharmaceuticals Inc
01/03/2023	09:03	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:PMVP	PMV Pharmaceuticals Inc